KFA
LEGN icon

Krane Funds Advisors’s Legend Biotech LEGN Stock Holding History

Krane Funds Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$909K Sell
31,488
-50
-0.2% -$1.35K 0.03% 100
2026
Q1 		$593K Buy
31,538
+2,720
+9% +$51.9K 0.02% 112
2025
Q4 		$627K Sell
28,818
-9,673
-25% -$277K 0.02% 99
2025
Q3 		$1.23M Buy
38,491
+4,330
+13% +$160K 0.03% 64
2025
Q2 		$1.21M Sell
34,161
-4,919
-13% -$159K 0.05% 26
2025
Q1 		$1.33M Buy
39,080
+22,036
+129% +$790K 0.04% 27
2024
Q4 		$555K Sell
17,044
-1,736
-9% -$71.9K 0.02% 35
2024
Q3 		$915K Sell
18,780
-1,180
-6% -$62.9K 0.03% 34
2024
Q2 		$884K Sell
19,960
-203
-1% -$9.37K 0.04% 30
2024
Q1 		$1.14M Sell
20,163
-277
-1% -$16.7K 0.05% 28
2023
Q4 		$1.23M Buy
20,440
+451
+2% +$28.6K 0.05% 30
2023
Q3 		$1.34M Sell
19,989
-65
-0.3% -$4.51K 0.06% 31
2023
Q2 		$1.38M Sell
20,054
-2,637
-12% -$172K 0.07% 29
2023
Q1 		$1.15M Buy
22,691
+262
+1% +$12.8K 0.05% 32
2022
Q4 		$1.12M Sell
22,429
-375
-2% -$18.2K 0.05% 31
2022
Q3 		$930K Buy
22,804
+1,264
+6% +$59.3K 0.05% 43
2022
Q2 		$1.19M Sell
21,540
-688
-3% -$29.1K 0.04% 47
2022
Q1 		$808K Buy
22,228
+1,819
+9% +$71.9K 0.03% 93
2021
Q4 		$951K Buy
20,409
+20,130
+7,215% +$1.02M 0.02% 68
2021
Q3 		$14K Hold
279
– – ﹤0.01% 298
2021
Q2 		$11K Sell
279
-103
-27% -$3.5K ﹤0.01% 293
2021
Q1 		$11K Hold
382
– – ﹤0.01% 287
2020
Q4 		$11K Buy
+382
New +$11K ﹤0.01% 292

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Krane Funds Advisors's LEGN Position: Q2 2026 in Review

Krane Funds Advisors reduced its Legend Biotech (LEGN) stake by 0.16% in Q2 2026, selling an estimated $1.35K and leaving 31,488 shares worth $909K. The position accounts for 0.03% of the portfolio, ranked #100.

Krane Funds Advisors first reported a position in LEGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.38M in Q2 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Krane Funds Advisors held 31,488 shares of Legend Biotech worth $909K as of Q2 2026.
  • Krane Funds Advisors sold 50 Legend Biotech shares in Q2 2026, an estimated $1.35K.
  • Legend Biotech made up 0.03% of Krane Funds Advisors's portfolio in Q2 2026, its #100 holding.
  • Krane Funds Advisors first reported a position in Legend Biotech in Q4 2020 and has held it in 23 quarters since.
  • Krane Funds Advisors's Legend Biotech position peaked at $1.38M in Q2 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Krane Funds Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.